Clinical Trial

Weak Pulse at Yang and Wiry Pulse at Yin Theory

Completed
View on ClinicalTrials.gov →
Summary
This is a clinical study to evaluate the effectiveness and explore the possible working mechanisms of a traditional Chinese herbal formula called Yixin Powder. The study focuses on patients with stable angina pectoris (chest pain) caused by coronary heart disease (CHD), who are diagnosed with a specific Chinese medicine pattern known as "qi deficiency and blood stasis," based on the "weak pulse at yang and wiry pulse at yin" theory. The study hypothesizes that adding Yixin Powder to standard Western medication will be beneficial for these patients. To test this, participants diagnosed with this condition will be randomly assigned to one of two groups. One group will receive standard medication alone, while the other group will receive the same standard medication plus Yixin Powder. The effects of the treatments will be compared between the two groups.
Trial Details
NCT Number NCT07378228
Lead Sponsor Xikun Li
Conditions Coronary Heart Disease, Stable Angina Pectoris
Enrollment 70 participants
Start Date 2023-07-01
Primary Completion 2024-06-01 (estimated)
Study Completion 2024-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-30